Patient recruitment forecasting in clinical trials using time-dependent Poisson-gamma model and homogeneity testing criteria
Volodymyr Anisimov, Lucas Oliver

TL;DR
This paper introduces a time-dependent Poisson-gamma model for more accurate patient recruitment forecasting in complex, multi-center clinical trials, addressing the limitations of traditional homogeneous rate models.
Contribution
It extends the classic PG model to incorporate non-homogeneous, time-dependent rates and develops new homogeneity testing methods for improved recruitment prediction accuracy.
Findings
The proposed model captures time-trends in recruitment data.
Homogeneity tests effectively identify rate variations.
Simulation results validate the model's forecasting capabilities.
Abstract
Clinical trials in the modern era are characterized by their complexity and high costs and usually involve hundreds/thousands of patients to be recruited across multiple clinical centres in many countries, as typically a rather large sample size is required in order to prove the efficiency of a particular drug. As the imperative to recruit vast numbers of patients across multiple clinical centres has become a major challenge, an accurate forecasting of patient recruitment is one of key factors for the operational success of clinical trials. A classic Poisson-gamma (PG) recruitment model assumes time-homogeneous recruitment rates. However, there can be potential time-trends in the recruitment driven by various factors, e.g. seasonal changes, exhaustion of patients on particular treatments in some centres, etc. Recently a few authors considered some extensions of the PG model to…
Peer Reviews
No public reviews on file for this paper yet. If you reviewed it on a platform where reviews are public (OpenReview, ICLR, NeurIPS, ICML), you can paste yours below so the community can read it here.
Videos
No videos yet. Explain this paper in a talk, walkthrough, or lecture? Add one.
Taxonomy
TopicsHealth Systems, Economic Evaluations, Quality of Life · Statistical Methods in Clinical Trials
